Allarity Therapeutics, Inc. Other General and Administrative Expense
Allarity Therapeutics, Inc. (ALLR) reported Other General and Administrative Expense of $268.00 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherGeneralAndAdministrativeExpense · last filed 2022-11-14
- Allarity Therapeutics, Inc. other general and administrative expense for the quarter ending 2022-09-30 was $268.00K, a 29.66% decline year-over-year.
- Allarity Therapeutics, Inc. other general and administrative expense for the quarter ending 2022-06-30 was $39.00K, a 86.32% decline year-over-year.
- Allarity Therapeutics, Inc. other general and administrative expense for the quarter ending 2022-03-31 was $703.00K.
- Allarity Therapeutics, Inc. other general and administrative expense for the quarter ending 2021-12-31 was -$666.00K.
| Period end | Other General and Administrative Expense 3 month | Other General and Administrative Expense 6 month | Other General and Administrative Expense 9 month | Other General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2022-09-30 | $268.00K 10-Q · filed 2022-11-14 | $307.00K derived: sum of 2 quarters · filed 2022-11-14 | $932.00K 10-Q · filed 2022-11-14 | $344.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | $39.00K 10-Q · filed 2022-10-07 | $664.00K 10-Q · filed 2022-10-07 | $76.00K derived: sum of 3 quarters · filed 2022-10-07 | $457.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-03-31 | $703.00K 10-Q · filed 2022-05-27 | $37.00K derived: sum of 2 quarters · filed 2022-05-27 | $418.00K derived: sum of 3 quarters · filed 2022-11-14 | $703.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-12-31 | -$666.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2022-05-27 | -$285.00K derived: sum of 2 quarters · filed 2022-11-14 | $0.00 derived: sum of 3 quarters · filed 2022-11-14 | $129.00K 10-Q · filed 2022-05-27 |
| 2021-09-30 | $381.00K 10-Q · filed 2022-11-14 | $666.00K derived: sum of 2 quarters · filed 2022-11-14 | $795.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $285.00K 10-Q · filed 2022-10-07 | $414.00K 10-Q · filed 2022-10-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |